Lundbeck
HLUN-B.CO
#2512
Rank
A$8.64 B
Marketcap
$9.07
Share price
0.26%
Change (1 day)
27.02%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): $0.53

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is $0.56. In 2022 the company made an earnings per share (EPS) of $0.43 a decrease over its 2021 EPS that were of $0.96.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.5324.39%
2022$0.43-55.47%
2021$0.96-51.83%
2020$1.99-28.01%
2019$2.77-44.08%
2018$4.9551.94%
2017$3.26126.64%
2016$1.44-120.84%
2015-$6.905622.18%
2014-$0.12-110.03%
2013$1.20-28.08%
2012$1.67-52.1%
2011$3.49-1.31%
2010$3.5415.61%
2009$3.06